OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PLRX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Pliant Therapeutics (PLRX) Earnings Date & Reports

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PLRX is expected to report earnings to fall 28.32% to -65 cents per share on August 11

Pliant Therapeutics PLRX Stock Earnings Reports

Q2'25

Est.

$-0.66

Q1'25

Missed

by $0.15

Q4'24

Beat

by $0.17

Q3'24

Beat

by $0.02

Q2'24

Missed

by $0.07

The last earnings report on May 08 showed earnings per share of -92 cents, missing the estimate of -76 cents. With 566.22K shares outstanding, the current market capitalization sits at 103.13M.

View a ticker or compare two or three

Compare

PLRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PLRX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PLRX showed earnings on May 08, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a company which engages in the business of developing and commercializing novel therapies for fibrotic diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

260 Littlefield Avenue

Phone

+1 650 481-6770

Employees

158

Web

https://www.pliantrx.com